XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Convertible Note Interest
The Mann Group L L C
At-the-market Placement
Common Stock
Common Stock
Convertible Note Interest
The Mann Group L L C
Common Stock
At-the-market Placement
Additional Paid-in Capital
Additional Paid-in Capital
Convertible Note Interest
The Mann Group L L C
Additional Paid-in Capital
At-the-market Placement
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance at Dec. 31, 2021 $ (209,349)     $ 2,515     $ 2,918,205       $ (3,130,069)
Beginning Balance (in shares) at Dec. 31, 2021       251,478              
Net issuance of common stock associated with stock options and restricted stock units 129     $ 4     125        
Net issuance of common stock associated with stock options and restricted stock units (in shares)       450              
Issuance of common stock under the employee stock purchase plan 740     $ 2     738        
Issuance of common stock under the employee stock purchase plan (in shares)       233              
Stock-based compensation expense 2,806           2,806        
Issuance of common stock from market price stock purchase plan 684     $ 3     681        
Issuance of common stock from Market Price Stock Purchase Plan (in shares)       252              
Cumulative loss on available-for-sale securities (1,076)                 $ (1,076)  
Net loss (25,998)                   (25,998)
Ending Balance at Mar. 31, 2022 (232,064)     $ 2,524     2,922,555     $ (1,076) (3,156,067)
Ending Balance (in shares) at Mar. 31, 2022       252,413              
Beginning Balance at Dec. 31, 2022 (250,538)     $ 2,638     2,964,293       (3,217,469)
Beginning Balance (in shares) at Dec. 31, 2022       263,793              
Net issuance of common stock associated with stock options and restricted stock units 52     $ 2     50        
Net issuance of common stock associated with stock options and restricted stock units (in shares)       206              
Stock-based compensation expense 3,655           3,655        
Issuance of common stock pursuant to conversion notes   $ 55           $ 55      
Issuance of common stock pursuant to conversion notes (in shares)         11            
Issuance of at-the-market placement     $ 1,199     $ 3     $ 1,196    
Issuance of at-the-market placement (in shares)           269          
Issuance costs associated with at-the- market placement (24)           (24)        
Net loss (9,795)                   (9,795)
Ending Balance at Mar. 31, 2023 $ (255,396)     $ 2,643     $ 2,969,225       $ (3,227,264)
Ending Balance (in shares) at Mar. 31, 2023       264,279